Our finding that kisspeptin administration also improves GSIS suggests that kisspeptin could have a dual therapeutic role in patients with diabetes to improve hypogonadism33 as well as enhance insulin release, specifically only when hyperglycaemia occurs (thereby potentially avoiding the risks of hypoglycaemia associated with other diabetes treatments). This evidence concerns the gene KISS1 and Hypoglycemia.